206 related articles for article (PubMed ID: 27357174)
1. Curative treatment of head and neck squamous cell carcinoma : Organ preservation strategies in clinical routine in German-speaking countries.
Kurzweg T; Kimmeyer J; Knecht R; Hoffmann TK; Busch CJ; Lörincz BB; Schuler PJ; Laban S
HNO; 2016 Jul; 64(7):501-7. PubMed ID: 27357174
[TBL] [Abstract][Full Text] [Related]
2. Palliative treatment standards for head and neck squamous cell carcinoma : Survey of clinical routine in German-speaking countries.
Laban S; Kimmeyer J; Knecht R; Hoffmann TK; Busch CJ; Veit JA; Möckelmann N; Kurzweg T
HNO; 2016 Jul; 64(7):487-93. PubMed ID: 27299894
[TBL] [Abstract][Full Text] [Related]
3. Oncologic treatment landscape for head and neck squamous cell carcinoma : Treatment infrastructure in German-speaking countries.
Kimmeyer J; Kurzweg T; Hoffmann TK; Knecht R; Veit JA; Möckelmann N; Münscher A; Laban S
HNO; 2016 Jul; 64(7):494-500. PubMed ID: 27286727
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Daly-Schveitzer N; Bourhis J; Tao Y
Anticancer Drugs; 2014 Nov; 25(10):1220-6. PubMed ID: 25144345
[TBL] [Abstract][Full Text] [Related]
5. Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM.
Alterio D; Franco P; Numico G; Licitra L; Cossu Rocca M; Ferrari A; Pinto C; Russi EG; Ricardi U; Jereczek Fossa BA
Med Oncol; 2016 Jul; 33(7):76. PubMed ID: 27290695
[TBL] [Abstract][Full Text] [Related]
6. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
Teo M; Karakaya E; Young CA; Dyker KE; Coyle C; Sen M; Prestwich RJ
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):647-53. PubMed ID: 23948462
[TBL] [Abstract][Full Text] [Related]
8. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
10. A swallow preservation protocol improves function for veterans receiving chemoradiation for head and neck cancer.
Peng KA; Kuan EC; Unger L; Lorentz WC; Wang MB; Long JL
Otolaryngol Head Neck Surg; 2015 May; 152(5):863-7. PubMed ID: 25829388
[TBL] [Abstract][Full Text] [Related]
11. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
12. [Study results of primary therapy for head and neck tumors : Highlights of the 2016 ASCO Annual Meeting].
Gliese A; Busch CJ; Knecht R
HNO; 2016 Oct; 64(10):717-22. PubMed ID: 27624903
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer.
Wang HM; Lin CY; Hsieh CH; Hsu CL; Fan KH; Chang JT; Huang SF; Kang CJ; Liao CT; Ng SH; Yen TC
J Formos Med Assoc; 2017 Mar; 116(3):185-192. PubMed ID: 27133181
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
Takácsi-Nagy Z; Hitre E; Remenár É; Oberna F; Polgár C; Major T; Gödény M; Fodor J; Kásler M
Strahlenther Onkol; 2015 Aug; 191(8):635-41. PubMed ID: 25782685
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of organ-preservation strategies in head and neck cancer in developing countries.
Trivedi NP; Kekatpure VD; Trivedi NN; Kuriakose MA; Shetkar G; Manjula BV
Indian J Cancer; 2012; 49(1):15-20. PubMed ID: 22842163
[TBL] [Abstract][Full Text] [Related]
16. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
Inohara H; Takenaka Y; Yoshii T; Nakahara S; Yamamoto Y; Tomiyama Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Ogawa K
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):934-41. PubMed ID: 25832686
[TBL] [Abstract][Full Text] [Related]
17. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
[TBL] [Abstract][Full Text] [Related]
19. Is there still a role for induction chemotherapy in locally advanced head and neck cancer?
Mak MP; Glisson BS
Curr Opin Oncol; 2014 May; 26(3):247-51. PubMed ID: 24651382
[TBL] [Abstract][Full Text] [Related]
20. Induction chemotherapy with cisplatin and ifosfamide in locally advanced inoperable squamous cell carcinoma of the head and neck: A single-institution experience.
Zaheer S; Siddiqui SA; Akram M; Hasan SA
Indian J Cancer; 2016; 53(3):372-376. PubMed ID: 28244461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
